Daniele Santini

Machine learning integrated explainable artificial intelligence in predicting toxicities of enfortumab vedotin in urothelial carcinoma: an exploratory study

Kannan Sridharan, Mattia Alberto Di Civita, Gowri Sivaramakrishnan, Luca Zacco et autres

bh, it, jp, cz, gb, my, ae, kr, gr, ch (code pays fourni par la source)

Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis

Mattia Alberto Di Civita, Laura Pappalardo, Danila De Angelis, Marco Stellato et autres

it (code pays fourni par la source)

Assessment of bone metastases, skeletal-related events and bone-targeting agents in patients with metastatic renal cell carcinoma receiving first-line systemic therapy (Meet-URO 33 study sub-analysis)

Anna Amela Valsecchi, Sara Elena Rebuzzi, Maria Concetta Cursano, Francesco Pantano et autres

it (code pays fourni par la source)

Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study)

Mimma Rizzo, Sebastiano Buti, Ondřej Fiala, Lorena Incorvaia et autres

it, cz, es, mx, jp, kr, at, gb, de, gr, be, br (code pays fourni par la source)

Prognostic value of systemic inflammatory markers in avelumab maintenance for advanced urothelial carcinoma: the multicentric SAILOR analysis

Brigida Anna Maiorano, Giandomenico Roviello, Alessandro Rizzo, Francesco Ciccimarra et autres

it, my, us (code pays fourni par la source)

Cardiovascular and Renal Risk Stratification in Patients Referred to an Onconephrology Clinic and Undergoing Different Oncology Therapies: A Real-World Study

Silvia Lai, Adolfo Marco Perrotta, Giovanni Pintus, Paolo Mené et autres

it (code pays fourni par la source)

Analysis of Torquetenovirus DNA levels in NSCLC patients treated with immune checkpoint inhibitors

Lilia Cinti, Lucrezia Tuosto, Piergiorgio Roberto, Roberta Campagna et autres

it (code pays fourni par la source)

Renal Involvement in Cancer Patients Undergoing Oncology Therapies: Implications for Personalized Treatment Strategies

Silvia Lai, A Punzo, Adolfo Marco Perrotta, Giuseppe Guaglianone et autres

it (code pays fourni par la source)

Kidney injury molecule‐1 (KIM-1) in localized and metastatic renal cell carcinoma (RCC): A meta-analysis and systematic review.

Mattia Alberto Di Civita, Marco Stellato, Mélanie Claps, Patrizia Giannatempo et autres

it (code pays fourni par la source)

Prognostic role of PIK3CA gene mutations in early-stage endometrial carcinoma in the context of the 2023 FIGO classification

Noemi Tonti, Federica Tomao, Sofia Mancini, Innocenza Palaia et autres

it (code pays fourni par la source)

Immunotherapy combinations in favourable risk score metastatic renal cell carcinoma, an individual patients data metanalysis

Mattia Alberto Di Civita, Daniele Marinelli, Valerio Marco Michetti, Adele Artemi et autres

it (code pays fourni par la source)

Beyond Pathological Complete Response: Risk-Adapted Interpretation of Neoadjuvant Immunotherapy Benefit in Early Breast Cancer

L. Sisca, M.G. Polito, Alessio Cortellini, Roberta Scafetta et autres